Reynolds Paula Rosput purchased $48K of LIN

Reynolds Paula Rosput purchased 100 shares of LINDE PLC (LIN) at $479.12 on 2026-08-18.

Original reporting
SEC EDGAR · Reynolds Paula Rosput
Published Aug 19, 2026, 7:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 7:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LIN
Neutral
high confidence
Mentioned
$LIN
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LINNeutralLow
01

Why it matters

The disclosed purchase is modest and unlikely to affect stock price materially.

02

Market read

Minor insider buy; limited trading relevance.

03

What to watch

Potential upcoming corporate actions or market conditions not disclosed could influence future insider behavior.

Relevance 4/10Novelty 4/10Timing: filed today

Background

Linde plc is a global industrial gases company; insider transactions are regularly monitored.

Company-level read

Ticker impact

$LINNeutralHigh confidence
Context

Director Paula Rosput bought 100 shares of Linde plc for $47,911, increasing her holding to 816 shares.

Expected impact

Minimal short-term price effect; may slightly support bullish sentiment.

Evidence & confidence

Form 4 filing is primary source; transaction size is under $50k, unlikely to move the stock materially.

Market effects

None significant; insider activity typical for large industrials.

None

None

Counterpoint

The purchase may be routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • Paula Rosput

    Director of Linde plc who purchased shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LINMedAI 8/10

Linde PLC (LIN) (Q3 2026) Earnings Call Highlights: Record Sales, Profit and EPS

Linde PLC (LIN) reported Q3 2026 record sales, profit, and EPS, but faced challenges in non-gas segments like Lincare, which reduced EPS growth by 2%. Q4 EPS guidance is $4.40-$4.50, a 3% sequential decline due to FX headwinds and seasonality. Europe and China markets remain weak. Management is evaluating strategic options for Lincare and expects no near-term recovery in Europe or China. Electronics growth is strong, supported by $2B in projects.

$LINMed

Linde plc Q3 2026 Earnings Call Summary

Linde plc reported Q3 2026 earnings, including a $425M restructuring charge. Lincare was moved to the Global Other segment. Chemicals and Energy grew 12%, Electronics 15%. Q4 EPS guidance is $4.40-$4.50. Management expects restructuring benefits by H2 2027 and Woodside ammonia project completion by H1 2027.

$LINMedAI 8/10

Linde Q3 Earnings Call Highlights

Linde (LIN) reported varied demand across regions and sectors in Q3, with electronics sales up 15% and chemicals/energy up 12%. U.S. packaged-gas growth remained in the low teens, while Europe saw flat market conditions. Linde's project backlog is near $8 billion, with the Woodside project expected to contribute financially in 2024. The company forecasted Q4 EPS of $4.40-$4.50, with full-year EPS at $17.82-$17.92.

$LINHighAI 8/10

Linde delivers a good quarter and puts in a fix for an overhang on the stock

Linde reported record Q3 revenue of $9.4B, up 9.2%, and adjusted EPS of $4.59, beating estimates. Shares fell 1% despite strong results due to light Q4 guidance. CEO addressed Lincare restructuring, taking a $425M charge. Sales grew in electronics, chemicals, and energy, with space propellant demand noted. Full-year EPS outlook raised to $17.87, in line with consensus. Linde maintains a $550 price target.